Linked Data API

Show Search Form

Search Results

384396
registered interest false more like this
date less than 2015-06-19more like thismore than 2015-06-19
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Social Services: Finance more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if his Department will update its impact assessment for funding reform to care and support services in England to take account of the Government's policy to increase inheritance tax thresholds by 2020. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 3345 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-29more like thismore than 2015-06-29
answer text <p>The Impact Assessment for funding reform to care and support sets out the costs and benefits of the reforms and was last updated in February 2013 to support the consultation on draft regulations and guidance. A final Impact Assessment will be published alongside the final regulations and guidance.</p><p> </p> more like this
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
question first answered
less than 2015-06-29T15:17:25.55Zmore like thismore than 2015-06-29T15:17:25.55Z
answering member
1201
label Biography information for Alistair Burt more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
348397
registered interest false more like this
date less than 2015-06-03more like thismore than 2015-06-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hidradenitis Suppurativa: Health Education more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to raise awareness of hidradenitis suppurativa. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 962 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-08more like thismore than 2015-06-08
answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
grouped question UIN
963 more like this
964 more like this
965 more like this
question first answered
less than 2015-06-08T10:53:58.267Zmore like thismore than 2015-06-08T10:53:58.267Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
348398
registered interest false more like this
date less than 2015-06-03more like thismore than 2015-06-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hidradenitis Suppurativa more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what estimate his Department has made of the number of people with hidradenitis suppurativa in the UK; how much his Department has spent on research into hidradenitis suppurativa in the last four years; and what guidance his Department gives on support to be given through the NHS for people with hidradenitis suppurativa. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 963 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-08more like thismore than 2015-06-08
answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
grouped question UIN
962 more like this
964 more like this
965 more like this
question first answered
less than 2015-06-08T10:54:00.79Zmore like thismore than 2015-06-08T10:54:00.79Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
348399
registered interest false more like this
date less than 2015-06-03more like thismore than 2015-06-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hidradenitis Suppurativa: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment his Department has made of the effectiveness of the care pathways for patients with hidradenitis suppurativa. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 964 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-08more like thismore than 2015-06-08
answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
grouped question UIN
962 more like this
963 more like this
965 more like this
question first answered
less than 2015-06-08T10:54:00.96Zmore like thismore than 2015-06-08T10:54:00.96Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
348400
registered interest false more like this
date less than 2015-06-03more like thismore than 2015-06-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hidradenitis Suppurativa: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department has taken to provide information to surgeons, dermatologists and general practitioners about hidradenitis suppurativa. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 965 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-08more like thismore than 2015-06-08
answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
grouped question UIN
962 more like this
963 more like this
964 more like this
question first answered
less than 2015-06-08T10:54:01.1Zmore like thismore than 2015-06-08T10:54:01.1Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
229457
registered interest false more like this
date less than 2015-03-19more like thismore than 2015-03-19
answering body
Cabinet Office more like this
answering dept id 53 more like this
answering dept short name Cabinet Office more like this
answering dept sort name Cabinet Office more like this
hansard heading Youth Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Minister for the Cabinet Office, what steps he is taking to support youth services. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 908320 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>We continue to offer practical support to the youth sector by promoting innovative delivery models for youth services and supporting organisations to measure their impact and demonstrate their value.</p><p>We have also provided over 130,000 opportunities for young people through National Citizen Service.</p><p> </p> more like this
answering member constituency Reading East more like this
answering member printed Mr Rob Wilson more like this
grouped question UIN
908317 more like this
908319 more like this
question first answered
less than 2015-03-25T17:29:38.803Zmore like thismore than 2015-03-25T17:29:38.803Z
answering member
1556
label Biography information for Mr Rob Wilson more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
228318
registered interest false more like this
date less than 2015-03-18more like thismore than 2015-03-18
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS Trusts: Finance more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many NHS trusts have (a) responded to the request from NHS England and Monitor to choose between the Enhanced Tariff Option and the Default Tariff Rollover for 2015-16 and (b) reserved the right to challenge those new tariff arrangements. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 228202 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-23more like thismore than 2015-03-23
answer text <p>A total of 211 out of 241 NHS trusts and foundation trusts (88% of all providers) have opted for the Enhanced Tariff Option (ETO). Of these, 90 were NHS trusts as opposed to NHS foundation trusts. Four NHS trusts wrote to Monitor reserving their right to legal challenge (one of whom had chosen the ETO option but placed conditions on this). The remaining NHS providers have either chosen or defaulted to the Default Tariff Rollover option.</p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-23T17:34:23.683Zmore like thismore than 2015-03-23T17:34:23.683Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
223315
registered interest false more like this
date less than 2015-02-24more like thismore than 2015-02-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Bowel Cancer: Screening more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the Government is doing to support endoscopy units to ensure that there is sufficient capacity in resources and staff for the roll-out of the bowel scope screening programme. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 225126 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-27more like thismore than 2015-02-27
answer text <p>Between May 2010 and November 2014, we have seen a 29.1% increase in consultant gastroenterologists, from 1,788 to 2,302.</p><p> </p><p> </p><p> </p><p><em>Delivering high quality, effective, compassionate care: Developing the right people with the right skills and the right values - A mandate from the Government to Health Education England: April 2014 to March 2015</em> states that Health Education England (HEE) will work with key partners to ensure that the National Health Service has available the right number of trained staff to deliver current and future demand for diagnostic tests. In particular, HEE will work with Public Health England and NHS England to ensure the availability of sufficient endoscopists to deliver bowel scope screening.</p><p> </p><p> </p><p> </p><p>A Joint Endoscopy Working Group, set up by NHS England's National Clinical Director for Diagnostics and Imaging, has been analysing the latest data, and an action plan is being developed to ensure sufficient capacity in the short and long term. The action plan will cover a wide range of organisations including HEE, NHS England, clinical commissioning groups and providers of endoscopy services. Potential actions identified include: developing robust endoscopy capacity and demand data; a national workforce strategy for endoscopy; supporting the training of non-medical endoscopists; including sufficient endoscopy capacity in business planning; and identifying new pathways and models of working.</p><p> </p><p> </p><p> </p><p>In addition NHS Improving Quality has developed The Productive Endoscopy Series, a set of self-directed learning resources that will help all staff working in endoscopy units to make better use of existing resources and deliver a more efficient and effective service to patients seven days a week.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-27T13:59:23.71Zmore like thismore than 2015-02-27T13:59:23.71Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
223316
registered interest false more like this
date less than 2015-02-24more like thismore than 2015-02-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Bowel Cancer: Screening more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many people have (a) been invited to take part in and (b) taken part in (i) the bowel scope screening programme and (ii) the faecal occult blood test programme to date. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 225127 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-27more like thismore than 2015-02-27
answer text <p>As at the end of January 2015, 83,153 invitations have been issued and 28,674 Bowel Scope Screening procedures have been performed. Uptake stood at approximately 44% and ranged from 38% in the lowest site to 51% in the highest. 1,173 people had been referred to colonoscopy following a Bowel Scope Screening with 29 cancers detected and 541 high/immediate risk polyps and 413 low risk polyps removed.</p><p> </p><p> </p><p> </p><p>The Bowel Scope Screening Programme is progressing well, having exceeded the Secretary of State’s commitment to have the programme rolled out to 30% of screening centres by the end of March 2014 and is on target to meet the 60% commitment by the end of March 2015. Around 28 centres now offer Bowel Scope Screening.</p><p> </p><p> </p><p> </p><p>At the end of January 2015, nearly 25 million Faecal Occult Blood test kits had been sent out to men and women aged 60-74 to self-sample at home. Over 15 million kits have been returned by post to one of 5 regional labs (programme hubs). Since the Programmes began in 2006, over 21,000 cancers have been detected and over 122,000 patients have been managed for polyps, including polyp removal.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-27T14:07:08.557Zmore like thismore than 2015-02-27T14:07:08.557Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
222986
registered interest false more like this
date less than 2015-02-23more like thismore than 2015-02-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Gastrointestinal System more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps he is taking to ensure that patients have timely and direct access to (a) gastroenterologists and (b) other specialist clinicians. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper remove filter
uin 224974 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-26more like thismore than 2015-02-26
answer text <p>Health Education England (HEE) is responsible for workforce planning and education commissioning activity to ensure that the National Health Service in England has available a future workforce in the right numbers, with the right skills, values and behaviours.</p><p> </p><p> </p><p> </p><p>In December 2014, HEE published its second national Workforce Plan for England for the period 2015/16 which is built upon the needs of local employers, commissioners and other stakeholders. The priorities in the plan are the priorities of the NHS, identified locally and nationally by employers, professional bodies and other stakeholders.</p><p> </p><p> </p><p> </p><p>National recruitment into gastroenterology training posts in 2013 and 2014 achieved 100% fill-rate. There have been no reductions in the planned commissions of gastroenterologists for 2015/16.</p><p> </p><p> </p><p> </p><p>The following table shows the number of full-time equivalent doctors and gastroenterologists, excluding locums, working in hospital and community health services in England.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Full-Time Equivalent</p></td><td><p>May 2010</p></td><td><p>November 2014</p></td><td colspan="2"><p>Change May 2010 to November 2014</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>All Doctors</p></td><td><p>95,421</p></td><td><p>105,001</p></td><td><p>9,580</p></td><td><p>10.0%</p></td></tr><tr><td><p><em>of which, with specialty of:</em></p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Gastroenterology</p></td><td><p>1,788</p></td><td><p>2,309</p></td><td><p>521</p></td><td><p>29.1%</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source:</em> Health and Social Care Information Centre, Monthly Workforce Statistics, Nov 2014</p><p> </p>
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
grouped question UIN 224978 more like this
question first answered
less than 2015-02-26T11:35:36Zmore like thismore than 2015-02-26T11:35:36Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
1538
label Biography information for Rosie Cooper more like this